Post by Lonza

Supply chain resilience continues to be a critical focus area across the pharmaceutical industry as companies navigate increasing complexity, evolving global dynamics, and growing demand for agility. At the upcoming DCAT (Drug, Chemical & Associated Technologies Association) Summit in Sitges, Barcelona, Jagruti Patel, Sr. Director, Commercial Development Integrated Biologics EMEA/AP at Lonza, will join industry experts for the panel discussion: 📍 Building a Resilient Pharma Supply Chain: Strategy, Risk & Innovation for the Future 📅 June 11 The session will explore how organizations are strengthening supply continuity through smarter partnerships, AI-enabled procurement, data-driven decision-making, and resilient global manufacturing strategies. We look forward to contributing to the discussion and connecting with industry peers at the DCAT Summit. #DCATSummit #SupplyChain #Biologics #PharmaceuticalManufacturing #CDMO #SupplyChainResilience #Innovation